首页> 外文会议>Advances in Laser and Light Spectroscopy to Diagnose Cancer and Other Diseases II >Innate tissue fluorescence of the oral mucosa of controls and head-and-neck cancer patients
【24h】

Innate tissue fluorescence of the oral mucosa of controls and head-and-neck cancer patients

机译:对照和头颈癌患者口腔黏膜的先天组织荧光

获取原文

摘要

Abstract: Base line spectral excitation and emission scans were defined for the oral mucosa in a population of 61 controls, 16 oral tongue cancer patients and 2 patients with tongue leukoplakia. A xenon-based fluorescence spectrophotometer (Mediscience Corp.) with a fiberoptic probe (Mediscience Corp.) was used to collect excitation and emission spectra. Two excitation scans ($lambda@Ex 200-360 nm, $lambda@Em 380 nm; $lambda@Ex 240-430 nm, $lambda@Em 450 nm) and two emission scans ($lambda@Ex 300 nm, $lambda@Em 320-580 nm; $lambda@Ex 340 nm, $lambda@Em 360-660 nm) were used to analyze the buccal mucosa (BM), hard palate (HP), floor of mouth (FOM) and dorsal tongue (DT) of 61 control individuals. In 41 controls the lateral tongue site (LT) was added. The same set of scans was performed on tumor lesions and contralateral normal tissues of 16 patients with lateral tongue tumors and on two individuals with leukoplakia of the tongue. Ratios of points on the individual scans were used to quantitate data. The excitation scan ($lambda@Ex 200-360 nm, $lambda@Em 380 nm) and the emission scan ($lambda@Ex 300 nm, $lambda@Em 320-580 nm) were able to statistically discriminate the HP and DT from the BM and FOM. The ratios of intensities of neoplastic mucosa and contralateral sites were significantly different with the excitation scans ($lambda@Ex 200-360 nm, $lambda@Em 380 nm, p $LS 0.001) and ($lambda@Ex 240-430 nm, $lambda@Em 450 nm, p $LS 0.01) and with the emission scan ($lambda@Ex 300 nm, $lambda@Em 320-580 nm, p $LS 0.001). Discrimination was significant with the emission scan ($lambda@Ex 340 nm, $lambda@Em 360- 660 nm, p $LS 0.07). Innate tissue fluorescence has potential as a monitor of cancer patients and populations at risk for head and neck cancer.!24
机译:摘要:在61名对照,16名口腔舌癌患者和2名舌白斑患者中定义了口腔黏膜的基线光谱激发和发射扫描。使用带有光纤探针(Mediscience Corp.)的基于氙气的荧光分光光度计(Mediscience Corp.)来收集激发和发射光谱。两次激发扫描($λb@ Ex 200-360 nm,$λb@ Em 380 nm; $ lambda @ Ex 240-430 nm,$ lambda @ Em 450 nm)和两次发射扫描($ lambda @ Ex 300 nm,$ lambda @Em 320-580 nm; $ lambda @ Ex 340 nm,$ lambda @ Em 360-660 nm)用于分析颊粘膜(BM),硬pa(HP),口底(FOM)和背舌( DT)的61个对照个体。在41个控件中添加了外侧舌头位置(LT)。对16例患有侧舌肿瘤的患者的肿瘤病变和对侧正常组织以及两名患有舌白斑的患者进行了相同的扫描。各个扫描的点数比率用于量化数据。激发扫描($ lambda @ Ex 200-360 nm,$ lambda @ Em 380 nm)和发射扫描($ lambda @ Ex 300 nm,$ lambda @ Em 320-580 nm)能够从统计学上区分HP和DT来自BM和FOM。肿瘤黏膜和对侧部位的强度比在激发扫描下显着不同(λlamb@ Ex 200-360 nm,λlambda@ Em 380 nm,p $ LS 0.001)和(λlambda@ Ex 240-430 nm, λλm@ Em 450 nm,p $ LS 0.01)和发射扫描(λλm@ Ex 300 nm,λlambda@ Em 320-580 nm,p $ LS 0.001)。发射扫描的分辨力很显着(λλ@ Ex 340 nm,λλEm360-660 nm,p $ LS 0.07)。固有组织荧光有可能作为癌症患者和处于头颈癌风险中的人群的监测器!24

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号